Barroso-Sousa, R. (2019) “TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)”, Mastology. Rio de Janeiro, 29(3), p. 5. doi: 10.29289/259453942019v29s1g04.